Share
Pharmacokinetics in Drug Development: Problems and Challenges in Oncology, Volume 4
Bonate, Peter L. ; Howard, Danny R. (Author)
·
Springer
· Paperback
Pharmacokinetics in Drug Development: Problems and Challenges in Oncology, Volume 4 - Bonate, Peter L. ; Howard, Danny R.
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: U.S.A.
(Import costs included in the price)
It will be shipped from our warehouse between
Tuesday, July 23 and
Tuesday, July 30.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Pharmacokinetics in Drug Development: Problems and Challenges in Oncology, Volume 4"
In this volume, the specific challenges and problems facing the evaluation of new oncology agents are explored with regards to pharmacokinetic, pharmacodynamic modeling and clinical pharmacology development strategies. This book delivers, with an emphasis on the oncology therapeutic area, the goals set in the first three volumes: namely - to provide clinical pharmacologists practical insights for the application of pharmacology, pharmacokinetics and pharmacodynamics for new drug development strategies. Pharmacokinetic-pharmacodynamic concepts for tyrosine kinases, the evaluation of cardiac repolarization prolongation through QTc interval effects, efficacy- and safety-response analyses to support new drug approvals, clinical and preclinical tumor growth modeling, and flat- vs weight-based dose selection are showcased from an oncology clinical pharmacologist's point-of-view. Oncology development strategies are surveyed for new FDA-approvals to identify patterns in expectations at time of first approval. The special considerations necessary to address combination drug development, metronomics, biosimilars and breakthrough therapies are also presented.
